AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 39 filers reported holding AQUINOX PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $77,000 | -48.3% | 26,298 | +149.1% | 0.00% | – |
Q1 2018 | $149,000 | -98.4% | 10,558 | -98.7% | 0.00% | -100.0% |
Q4 2017 | $9,542,000 | -30.2% | 811,371 | -15.8% | 0.00% | -33.3% |
Q3 2017 | $13,667,000 | +0.9% | 963,147 | +0.0% | 0.00% | -25.0% |
Q2 2017 | $13,548,000 | -16.1% | 962,896 | -0.5% | 0.00% | 0.0% |
Q1 2017 | $16,153,000 | +1.0% | 967,832 | -0.1% | 0.00% | -20.0% |
Q4 2016 | $15,995,000 | +20.7% | 968,819 | -2.3% | 0.01% | +25.0% |
Q3 2016 | $13,248,000 | +109.1% | 991,597 | +3.6% | 0.00% | +100.0% |
Q2 2016 | $6,336,000 | -26.0% | 957,166 | -1.4% | 0.00% | -33.3% |
Q1 2016 | $8,558,000 | +3703.6% | 970,317 | +5277.2% | 0.00% | – |
Q4 2015 | $225,000 | – | 18,045 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Boxer Capital, LLC | 877,753 | $14,492,000 | 5.61% |
RA Capital Management | 2,191,977 | $36,190,000 | 5.13% |
Opaleye Management Inc. | 310,000 | $5,118,000 | 3.02% |
EMORY UNIVERSITY | 143,691 | $2,372,000 | 2.34% |
Baker Brothers Advisors | 10,536,092 | $173,951,000 | 1.70% |
Ghost Tree Capital, LLC | 225,000 | $3,715,000 | 0.89% |
Cormorant Asset Management, LP | 151,838 | $2,507,000 | 0.34% |
Eventide Asset Management | 175,000 | $2,889,000 | 0.19% |
JGP Global Gestao de Recursos Ltda. | 11,380 | $188,000 | 0.10% |
Virtus ETF Advisers LLC | 16,347 | $270,000 | 0.08% |